These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. ZBTB44-FLT3 fusion in a patient with a myeloproliferative neoplasm. Zhou X; Yang C; Zou Z; Lang X; Chen P; Chen S; Wang K; Chen Y; Hao Y; Chen N; Ding J; Li Y; Shen Y; Xiao S Br J Haematol; 2020 Oct; 191(2):297-301. PubMed ID: 32866288 [No Abstract] [Full Text] [Related]
26. Establishing specific response criteria for MDS/MPN - Getting closer to reality? Villaume MT; Savona MR Best Pract Res Clin Haematol; 2020 Jun; 33(2):101170. PubMed ID: 32460975 [No Abstract] [Full Text] [Related]
27. Sequential B-lymphoid and myeloid blastic transformation of Philadelphia chromosome-negative myeloproliferative neoplasm. Hu AY; Zhou T Br J Haematol; 2019 Jan; 184(1):8. PubMed ID: 30407632 [No Abstract] [Full Text] [Related]
28. Focus on the epigenome in the myeloproliferative neoplasms. Kim E; Abdel-Wahab O Hematology Am Soc Hematol Educ Program; 2013; 2013():538-44. PubMed ID: 24319229 [TBL] [Abstract][Full Text] [Related]
29. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders. Bench AJ; Erber WN; Scott MA Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721 [TBL] [Abstract][Full Text] [Related]
30. Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia. Arefi M; Robledo C; Peñarrubia MJ; García de Coca A; Cordero M; Hernández-Rivas JM; García JL Eur J Haematol; 2014 Nov; 93(5):422-8. PubMed ID: 24813417 [TBL] [Abstract][Full Text] [Related]
31. Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies. Guezguez B Curr Opin Hematol; 2021 Sep; 28(5):345-346. PubMed ID: 34261881 [No Abstract] [Full Text] [Related]
32. Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10). Visconte V; Tabarroki A; Zhang L; Hasrouni E; Gerace C; Frum R; Ai J; Advani AS; Duong HK; Kalaycio M; Saunthararajah Y; Sekeres MA; His ED; Shetty S; Rogers HJ; Tiu RV Am J Hematol; 2014 Aug; 89(8):862. PubMed ID: 24796269 [No Abstract] [Full Text] [Related]
33. Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender. Patterson-Fortin J; Moliterno AR Curr Hematol Malig Rep; 2017 Oct; 12(5):424-431. PubMed ID: 28948454 [TBL] [Abstract][Full Text] [Related]
34. JAK2 (and other genes) be nimble with MPN diagnosis, prognosis, and therapy. Ciboddo M; Mullally A Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):110-117. PubMed ID: 30504299 [TBL] [Abstract][Full Text] [Related]
35. Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes. Hamidi A; Roloff GW; Shaw R; Acevedo M; Smith S; Drazer MW Leuk Lymphoma; 2023 Sep; 64(9):1562-1565. PubMed ID: 37294121 [TBL] [Abstract][Full Text] [Related]
36. Concomitant presence of JAK2V617F mutation and BCR‑ABL translocation in two patients: A new entity or a variant of myeloproliferative neoplasms (Case report). Mousinho F; Azevedo AP; Mendes T; Santos PSE; Cerqueira R; Matos S; Santos S; Ramos S; Viana JF; Lima F Mol Med Rep; 2018 Jul; 18(1):1001-1006. PubMed ID: 29845291 [TBL] [Abstract][Full Text] [Related]
37. Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review. Konishi Y; Kondo T; Nakao K; Asagoe K; Otsuka Y; Nishikori M; Hishizawa M; Yamashita K; Takaori-Kondo A Bone Marrow Transplant; 2019 Feb; 54(2):326-329. PubMed ID: 30087462 [No Abstract] [Full Text] [Related]
38. Non-internal tandem duplication (ITD), non-tyrosine kinase domain (TKD) FLT3 mutations in myeloid malignancies: A brief report of 10 patients. Higgins A; Mangaonkar AA; Hefazi M; Viswanatha D; Horna P; Foran J; Gangat N Leuk Res; 2018 Sep; 72():1-4. PubMed ID: 30055376 [No Abstract] [Full Text] [Related]
39. How I investigate basophilia in daily practice. Feriel J; Depasse F; Geneviève F Int J Lab Hematol; 2020 Jun; 42(3):237-245. PubMed ID: 31841278 [TBL] [Abstract][Full Text] [Related]
40. Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS. Alberti MO; Srivatsan SN; Shao J; McNulty SN; Chang GS; Miller CA; Dunlap JB; Yang F; Press RD; Gao Q; Ding L; Heusel JW; Duncavage EJ; Walter MJ Leukemia; 2018 Aug; 32(8):1874-1878. PubMed ID: 29959414 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]